20
Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingelheim Am Rhein De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Phenylephrine, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2003-167 - Rev 00
This Chemical Type CEP, issued on July 20, 2009, remains in force until July 19, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 1035 associated with this CEP further emphasizes